COR vs VTRS
COR: Cencora is a critical link in the global healthcare supply chain, providing pharmaceutical distribution, commercialization services, and specialty drug support to ensure patients have access to life-saving medications. VTRS: Viatris is a global healthcare company providing a broad range of high-quality, affordable medicines across both developed and emerging markets.
Side-by-side fundamentals
| Metric | COR | VTRS | Edge |
|---|---|---|---|
| Price as of 2026-08-07 close | $320.46 | $16.43 | |
| Market cap as of 2026-08-09 | $61.2B | $19.1B | |
| P/E as of 2026-08-09 | 23.30 | n/a | |
| PEG as of 2026-08-09 | 2.26 | 1.68 | VTRS lower |
| Net margin as of 2026-08-09 | +0.8% | -2.8% | COR higher |
| Gross margin as of 2026-08-09 | +4.0% | +40.3% | VTRS higher |
| Operating margin as of 2026-08-09 | +0.9% | -0.9% | COR higher |
| ROE as of 2026-08-09 | +104.4% | -2.8% | COR higher |
| ROA as of 2026-08-09 | +3.3% | -1.1% | COR higher |
| Debt / equity as of 2026-08-09 | 3.62 | 0.94 | VTRS lower |
| Revenue growth (YoY) as of 2026-08-09 | +5.1% | +4.4% | COR higher |
| Revenue CAGR (3y) SEC XBRL | +10.4% | -4.2% | COR higher |
| Dividend yield as of 2026-08-09 | +0.7% | +2.7% | VTRS higher |
| Dividend streak (yrs) SEC XBRL | 4 | 5 | VTRS higher |
| Beta as of 2026-08-09 | 0.57 | 0.87 | |
| 1-year return as of 2026-08-07 close | +15.1% | +75.0% | VTRS higher |
Fundamentals: market data, as of 2026-08-09. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-08-07.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.